About 16% of the population in Croatia is older than 65 years. Croatia has no register of persons with
dementia (PWD), but based on a calculation that 10% of persons over 65 years are affected by dementia,
the approximate number of PWD would be 80,000, the majority being patients with Alzheimer’s disease
(AD). Psychogeriatric departments exist in hospitals, but there are almost no nursing homes and an
insufficient number of daily care centres for PWD. Antidementia drugs registered in Croatia are donepezil,
rivastigmine and memantine. Clinical studies of new antidementia drugs have been conducted in Croatia
since 1989. At present, studies of several antidementia drugs are underway at different testing stages.